EG20677A - Method and an apparatus for micronizing the particle size - Google Patents

Method and an apparatus for micronizing the particle size

Info

Publication number
EG20677A
EG20677A EG60594A EG60594A EG20677A EG 20677 A EG20677 A EG 20677A EG 60594 A EG60594 A EG 60594A EG 60594 A EG60594 A EG 60594A EG 20677 A EG20677 A EG 20677A
Authority
EG
Egypt
Prior art keywords
agglomerates
micronizing
particle size
spheronizing
spheronization
Prior art date
Application number
EG60594A
Other languages
English (en)
Original Assignee
Astra Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9303214A external-priority patent/SE9303214D0/xx
Priority claimed from SE9304271A external-priority patent/SE9304271D0/xx
Application filed by Astra Ag filed Critical Astra Ag
Application granted granted Critical
Publication of EG20677A publication Critical patent/EG20677A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Multiple Motors (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Glanulating (AREA)
  • Exchange Systems With Centralized Control (AREA)
  • Stereophonic System (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG60594A 1993-10-01 1994-09-29 Method and an apparatus for micronizing the particle size EG20677A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9303214A SE9303214D0 (sv) 1993-10-01 1993-10-01 Process I
SE9304271A SE9304271D0 (sv) 1993-12-22 1993-12-22 Process I
US08/317,033 US5551489A (en) 1993-10-01 1994-10-03 Agglomeration of finely divided powders

Publications (1)

Publication Number Publication Date
EG20677A true EG20677A (en) 1999-11-30

Family

ID=27355730

Family Applications (1)

Application Number Title Priority Date Filing Date
EG60594A EG20677A (en) 1993-10-01 1994-09-29 Method and an apparatus for micronizing the particle size

Country Status (23)

Country Link
US (1) US5551489A (de)
EP (1) EP0721331B1 (de)
JP (1) JP3732508B2 (de)
CN (1) CN1110300C (de)
AT (1) ATE209903T1 (de)
AU (1) AU679789B2 (de)
BR (1) BR9407686A (de)
CZ (1) CZ289214B6 (de)
DE (1) DE69429357T2 (de)
DK (1) DK0721331T3 (de)
EG (1) EG20677A (de)
ES (1) ES2166786T3 (de)
FI (1) FI116364B (de)
HU (1) HU222355B1 (de)
IL (1) IL111080A (de)
NO (1) NO314836B1 (de)
NZ (1) NZ274277A (de)
PL (1) PL175564B1 (de)
PT (1) PT721331E (de)
RU (1) RU2170082C2 (de)
SG (1) SG48049A1 (de)
SK (1) SK283569B6 (de)
WO (1) WO1995009615A1 (de)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
DE19522899C1 (de) * 1995-06-23 1996-12-19 Hexal Pharmaforschung Gmbh Verfahren zum kontinuierlichen Ersintern eines Granulats
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9616047D0 (en) * 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
EP1393721B1 (de) * 1997-03-20 2008-11-26 Schering Corporation Dosierungsform eines Pulveragglomerates
EP0876814A1 (de) 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Trägerstoff für Trockenpulverinhalator, Verfahren zu dessen Herstellung und diesen enthaltende Arzneimittel
US6182712B1 (en) 1997-07-21 2001-02-06 Inhale Therapeutic Systems Power filling apparatus and methods for their use
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US20020010197A1 (en) * 1998-01-13 2002-01-24 John Dixon Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US7304750B2 (en) 1999-12-17 2007-12-04 Nektar Therapeutics Systems and methods for non-destructive mass sensing
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
CA2433335C (en) * 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
EP1370543B1 (de) 2001-02-14 2006-10-25 Tibotec Pharmaceuticals Ltd. Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren
EP1397367A2 (de) 2001-04-09 2004-03-17 Tibotec Pharmaceuticals Ltd. Breitspektrum-2-(amino substituierte)-benzoxazol-sulfonamid-hiv-protease-inhibitoren für die entdeckung entfernter zellulärer signale durch nukleozytoplasmatisches zyklisieren
US7622490B2 (en) 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
CA2465675C (en) * 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7763641B2 (en) 2001-12-21 2010-07-27 Tibotec Pharmaceuticals Ltd. Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
CA2485903C (en) 2002-05-17 2011-08-16 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
NZ538714A (en) 2002-08-14 2007-03-30 Tibotec Pharm Ltd Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
EP1417958A1 (de) * 2002-11-08 2004-05-12 Pari GmbH Feuchtgranulierungsverfahren
CA2531766C (en) 2003-09-11 2012-11-27 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the hiv virus
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
AU2005244121B2 (en) 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
MXPA06013315A (es) 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
KR20070015608A (ko) 2004-05-17 2007-02-05 티보텍 파마슈티칼즈 리미티드 1-헤테로사이클일-1,5-디히드로-피리도[3,2-ｂ]인돌-2-온
TW200607502A (en) 2004-05-17 2006-03-01 Tibotec Pharm Ltd 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
AR056652A1 (es) 2005-04-11 2007-10-17 Tibotec Pharm Ltd Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
WO2007045496A1 (en) 2005-10-21 2007-04-26 Universiteit Antwerpen Novel urokinase inhibitors
RU2008143342A (ru) 2006-04-03 2010-05-10 Тиботек Фармасьютикалз Лтд. (Ie) 3, 4-дигидроимидазо(4, 5-b)пиридин-5-оны, ингибирующие вич(hiv)
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
EP2116236A1 (de) 2008-04-21 2009-11-11 Université de Mons-Hainaut Bisbenzamidinderivate als Antioxidationsmittel
JP2012524817A (ja) * 2009-04-24 2012-10-18 シェーリング コーポレイション 標的粒子サイズを有する、活性医薬を含む凝集体配合物
NZ602191A (en) 2010-03-02 2014-07-25 Amakem Nv Heterocyclic amides as rock inhibitors
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
GB201019043D0 (en) 2010-11-10 2010-12-22 Protea Biopharma N V Use of 2',5'-oligoadenylate derivative compounds
GB201102237D0 (en) 2011-02-09 2011-03-23 Kuecept Ltd Particle formulation
GB201108225D0 (en) 2011-05-17 2011-06-29 Amakem Nv Novel KBC inhibitors
GB201113689D0 (en) 2011-08-09 2011-09-21 Amakem Nv Novel PDE4 inhibitors
GB201114854D0 (en) 2011-08-29 2011-10-12 Amakem Nv Novel rock inhibitors
EP2751079A1 (de) 2011-08-31 2014-07-09 Amakem NV Biphenylcarbonsäureamide als rock-kinasehemmer
PT2760453T (pt) 2011-09-30 2016-08-02 Ipsen Pharma Sas Inibidores macrocíclicos da cinase lrrk2
MX347765B (es) 2011-09-30 2017-05-12 Oncodesign Sa Inhibidores macrociclicos de la quinasa flt3.
EP2810198B1 (de) 2012-01-30 2023-07-12 Universiteit Gent Antiinvasive verbindungen
GB201204756D0 (en) 2012-03-19 2012-05-02 Lewi Paulus J Triazines with suitable spacers for treatment and/or prevention of HIV infections
WO2014072419A1 (en) 2012-11-08 2014-05-15 Universiteit Antwerpen Novel anti-hiv compounds
CA2906262A1 (en) 2013-03-15 2014-09-18 Oncodesign S.A. Macrocyclic salt-inducible kinase inhibitors
US9427376B2 (en) * 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
WO2015150337A1 (en) 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors
WO2016003450A1 (en) 2014-07-01 2016-01-07 The Regents Of The University Of California Pkc-epsilon inhibitors
WO2016005340A1 (en) 2014-07-08 2016-01-14 Universiteit Gent Hamamelitannin analogues and uses thereof
ES2717510T3 (es) 2014-09-17 2019-06-21 Oncodesign Sa Inhibidores macrocíclicos de cinasa LRRK2
AU2015316799B2 (en) 2014-09-17 2019-07-11 Oncodesign Precision Medicine (OPM) Macrocyclic RIP2 kinase inhibitors
WO2016083490A1 (en) 2014-11-27 2016-06-02 Remynd Nv Compounds for the treatment of amyloid-associated diseases
WO2016146651A1 (en) 2015-03-16 2016-09-22 Oncodesign Sa Macrocyclic activin-like receptor kinase inhibitors
WO2017146994A1 (en) * 2016-02-24 2017-08-31 Merck Sharp & Dohme Corp. Controlled agglomeration of micronized drug or drug-excipient mixtures
WO2017157882A1 (en) 2016-03-14 2017-09-21 Université Catholique de Louvain Serine biosynthetic pathway inhibitors
WO2018065387A1 (en) 2016-10-04 2018-04-12 Universiteit Gent Novel hamamelitannin analogues and uses thereof
WO2018096088A1 (en) 2016-11-24 2018-05-31 Universiteit Antwerpen Halogenated benzotropolones as atg4b inhibitors
WO2018138358A1 (en) 2017-01-30 2018-08-02 Université de Liège Perk and ire-1a inhibitors against neurodevelopmental disorders
US12178805B2 (en) 2017-05-11 2024-12-31 Remynd N.V. Inhibitors of PDE6Delta for use in the prevention and/or treatment of epilepsy and/or neurodegenerative disorders
PL3621963T3 (pl) 2017-05-11 2024-05-20 Remynd N.V. Związki do leczenia epilepsji, zaburzeń neurodegeneracyjnych i innych zaburzeń oun
CA3135420A1 (en) 2018-04-05 2019-10-10 Universiteit Hasselt Selective pde4d inhibitors against demyelinating diseases
CA3110661A1 (en) 2018-08-29 2020-03-05 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
AU2020274407B2 (en) 2019-05-14 2023-09-28 Suzhou Four Health Pharmaceuticals Co., Ltd Quinazoline-2,4-dione derivatives as PARP inhibitors
WO2022157381A1 (en) 2021-01-25 2022-07-28 Universiteit Hasselt Phloretin for use in the treatment of neurodegenerative and demyelinating diseases
EP4387629A1 (de) 2021-08-18 2024-06-26 Katholieke Universiteit Leuven KU Leuven Research & Development 6-substituierte und 6,7-disubstituierte 7-deazapurin-ribonukleosidanaloga
US20250066365A1 (en) 2021-09-23 2025-02-27 Katholieke Universiteit Leuven Ribonucleoside Analogues Against -Sars-Cov-2
WO2023241799A1 (en) 2022-06-15 2023-12-21 Université Libre de Bruxelles Flavanols for use in the treatment of retroviral infections

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2609150A (en) * 1949-11-05 1952-09-02 Union Carbide & Carbon Corp Mechanical pulverization of refrigerated plastics
NL128302C (de) * 1960-03-25 1900-01-01
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3802822A (en) * 1972-03-01 1974-04-09 Mars Mineral Corp Pelletizer
GB1569611A (en) * 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
GB1520247A (en) * 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4161526A (en) * 1978-07-20 1979-07-17 Sterling Drug Inc. Zinc salt prevention or removal of discoloration in pyrithione, pyrithione salt and dipyrithione compositions
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US4688610A (en) * 1985-03-19 1987-08-25 Spiral Systems Inc. Apparatus for dispensing particulate agglomerating solids
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
GB8606762D0 (en) * 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
JPS63116732A (ja) * 1986-11-06 1988-05-21 Fukae Kogyo Kk 粉粒体処理装置
GB8711005D0 (en) * 1987-05-09 1987-06-10 British Petroleum Co Plc Chemical process
EP0441740B1 (de) * 1990-01-29 1993-09-22 Ciba-Geigy Ag Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments

Also Published As

Publication number Publication date
NO961290L (no) 1996-03-29
CN1110300C (zh) 2003-06-04
PL313765A1 (en) 1996-07-22
HUT74519A (en) 1997-01-28
RU2170082C2 (ru) 2001-07-10
AU7826194A (en) 1995-05-01
CZ94296A3 (en) 1996-06-12
WO1995009615A1 (en) 1995-04-13
AU679789B2 (en) 1997-07-10
BR9407686A (pt) 1997-02-04
US5551489A (en) 1996-09-03
FI961430L (fi) 1996-03-29
ES2166786T3 (es) 2002-05-01
JP3732508B2 (ja) 2006-01-05
NO961290D0 (no) 1996-03-29
HU222355B1 (hu) 2003-06-28
CZ289214B6 (cs) 2001-12-12
SG48049A1 (en) 1998-04-17
DE69429357T2 (de) 2002-08-14
ATE209903T1 (de) 2001-12-15
PL175564B1 (pl) 1999-01-29
NO314836B1 (no) 2003-06-02
IL111080A0 (en) 1994-11-28
EP0721331B1 (de) 2001-12-05
CN1132476A (zh) 1996-10-02
NZ274277A (en) 1998-01-26
DK0721331T3 (da) 2002-02-11
SK39196A3 (en) 1997-06-04
SK283569B6 (sk) 2003-09-11
DE69429357D1 (de) 2002-01-17
FI961430A0 (fi) 1996-03-29
FI116364B (fi) 2005-11-15
JPH09504224A (ja) 1997-04-28
EP0721331A1 (de) 1996-07-17
IL111080A (en) 1999-08-17
PT721331E (pt) 2002-05-31
HU9600821D0 (en) 1996-05-28

Similar Documents

Publication Publication Date Title
PL313765A1 (en) Process i
RU96108803A (ru) Способ обработки лекарственного средства, устройство и его применение, агломераты
MX9709448A (es) Metodos y sistemas para procesar polvos finos dispersables.
NZ332961A (en) Powder filling systems, apparatus and methods
EP0395026A3 (de) Magnetischer Entwickler, Bildherstellungsverfahren und Bildherstellungsapparat
MY111994A (en) Process and apparatus for mixing cohesive powders
CA2062382A1 (en) Magnetic toner, image forming method, surface-modified fine silica powder and process for its production
SG44763A1 (en) Magnetic toner process cartridge and image forming method
GB9026362D0 (en) Inorganic material slurry
FR2317013A1 (fr) Procede et dispositif pour la preparation de matieres par separation magnetique
EP0357376A3 (de) Feine Farbteilchen und sie enthaltender Toner für die Entwicklung elektrostatischer Bilder
AU6335890A (en) Apparatus for preparing, classifying and metering particle media
EP0253054A3 (de) Tonersystem
MX9504457A (es) Polvo de flujo libre para moldeo que comprende politetrafluoroetileno.
EP0982379A3 (de) Verfahren und vorrichtung zur modifizierung von Partikeloberflächen
TW350935B (en) Toner composition for electrostatic charge development and image forming process using the same
AU578400B2 (en) Vibratory grinding of silicon carbide
EP0179379A3 (en) Method for electrostatically spraying inorganic particles
ES8107044A1 (es) Perfeccionamientos en los dispositivos de introduccion de lacorriente gaseosa en los aparatos de granulacion y-o recu- brimiento en lecho en surtidor
UA19458C2 (uk) Вогhегасhий порошок багатоцільового призhачеhhя
KR910004725A (ko) 수지에 배합하여 사용하는 제라틴입자 및 아미노산입자
Yaglo Texturing and ultrasound processing of magnetic powders
EP0641587A3 (de) Verfahren zum Auftrennen einer Dispersion von Partikeln in Flüssigkeiten in einen mit Partikeln angereicherten und einen an Partikeln verarmten Teilstrom.
MY111802A (en) Agglomeration of finely divided powders.
MY104203A (en) Nonpigmentary titanium dioxide powders.